Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how...
Read More
What is a Place in the new NHS structure? What role will Place leaders have in decision-making? What will this new structure mean for the way Pharma and Medtech engage...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what...
Read More
How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits...
Read More
How can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the...
Read More
What role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up...
Read More
Population health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems develop? How will personal needs inform care delivery?...
Read More
What will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders have? As the NHS starts its...
Read More
What changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? What will the introduction of medicines registers, as outlined in the Government’s Health and...
Read More
